First clinical report of helical tomotherapy with simultaneous integrated boost for synchronous bilateral breast cancer

Abstract

Women with SBBC can be safely treated with HT and this is not associated with adverse short- to intermediate term radiation toxicity. Advances in knowledge: This is the first report that establishes the safety of HT for adjuvant RT using SIB technique in SBBC.